Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC
NCT01259193
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Sorafenib and Zoledronic Acid
Sponsor
Fudan University